St. Elizabeth'sServices and Clinical CentersPulmonary Research

Research

The Division of Pulmonary, Critical Care and Sleep Medicine is focused on clinical and translational research and the development of new devices and technologies, often times in collaboration with industry partners. Due to our reputation, research facilities, patient volume and our commitment to improving the lives of our patients, we are intimately involved with the development and testing of multiple new devices and drugs in pre-clinical and Phase I, II, and III human clinical trials. With interests in chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease, and lung cancer, our physicians are uniquely qualified to bring the latest advancements in research to our patients.

The following is a partial list of active clinical trials open for enrollment (click on the protocol titles to be directed to each study’s respective clinicaltrials.gov webpage):

Pulmonary Fibrosis

Principal Investigator: Dr. Peter LaCamera
Goal: To evaluate the efficacy of FG-3019 in slowing the loss of forced vital capacity (FVC) and the progression of IPF along with the safety and tolerability of FG-3019 in these subjects.

Emphysema/COPD

Principal Investigator: Dr. Samaan Rafeq
Goal: To investigate the safety and effectiveness of the Pulmonx EBV for treating emphysema symptoms as compared to a standard medical therapy program alone. It is hypothesized that after placement of the EBV, lung function will be improved as compared to standard medical therapy alone.

Asthma

Principal Investigator: Dr. Samaan Rafeq
Goal: To evaluate the short- and long-term benefit and safety of bronchial thermoplasty for the treatment of severe persistent asthma.

The Division of Pulmonary, Critical Care and Sleep Medicine has a dedicated Research Office to help patients through the process of enrolling into a study. Please contact Arthur Dea, CCRP, at 617-789-2078, or Katherine Herrick at 617-779-6792, if you would like to learn more about pulmonary research, potentially enroll into one of these active trials, and/or be added onto the pulmonary registry for future studies. You may also email pulmonary@steward.org for additional information.


Connect with Steward

Visit Our Twitter Feed Visit Our Facebook Page Visit Our YouTube Channel Email This Page Share This Page Print This Page

Subscribe to Believe

Our electronic health news
Steward DoctorFinder Thomson Reuters 100 Top Hospitals 2011 The Joint Commission National Quality Approval Seal Blue Cross Blue Shield Distinction Center for Spine Surgery Designated as Blue Distinction Center for Knee and Hip Replacement by Blue Cross Blue Shield of Massachusetts Interpreter Services American Heart Association - stroke and cardiovascular Commission on Cancer The Leapfrog Group - A Hospital Safety Score
Copyright © 2014 Steward Health Care
Connect Healthcare Panacea CMS Solutions